Cargando…
Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
Research investigators have shown a growing interest in investigating alterations underlying skeletal muscle wasting in patients with cancer. However, skeletal muscle dysfunctions associated with cancer cachexia have mainly been studied in preclinical models. In the present review, we summarize the...
Autores principales: | Dolly, Adeline, Dumas, Jean‐François, Servais, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749617/ https://www.ncbi.nlm.nih.gov/pubmed/33053604 http://dx.doi.org/10.1002/jcsm.12633 |
Ejemplares similares
-
The Science of Soy: What Do We Really Know?
por: Barrett, Julia R.
Publicado: (2006) -
Dark matter: what do we really know
por: Tao, C
Publicado: (2013) -
Pyorrhea Alveolaris—What Do We Really Know of It
por: Trueman, W. H.
Publicado: (1897) -
COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020) -
What Do We Really Know About Neutron Stars?
por: Woltjer, Lodewijk
Publicado: (2003)